Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030005/S257

VALITUDE (Model U125); VALITUDE X4 (Model U128); VISIONIST (Models U225, U226); VISIONIST X4 (Model U228)

Guidant Corp. · Decision date Oct 3, 2026

MEDTECHLEDGER EXPLANATIONP030005/S257

What did the FDA decide?

This 30-day notice for P030005/S257 records a process change for Guidant Corp. pacemaker and CRT-P models. The stated purpose is to add an acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification.

The supplement type is a process change involving manufacturer, sterilizer, packager, or supplier. The decision field reads OK30. The source statement does not describe any clinical testing, safety data, or effectiveness evidence, and it does not identify which specification changed or what the new acceptance activity entails.

FDA approval order statement

to implement an additional acceptance activity for Accolade SL batteries and to change a specification for an existing Accolade EL battery specification
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 3, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P030005/S257
Regulatory pathway
PMA supplement
Applicant
Guidant Corp.
Product code
NKE
Decision code
OK30
Decision date
Oct 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P).

Applicant
Guidant Corp.
Product code
NKE
FDA device class
3

For the original device and its historical approval scope, see PMA P030005. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P030005 · Original PMA

    CONTAK RENEWAL MODELS H125 AND H120 WITH THE MODEL 2865 VERSION 1.8 APPLICATION SOFTWARE

  2. P030005/S257 received

    Application receipt date recorded by FDA.

  3. P030005/S257 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P030005. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030005

Product / regulatory recordCompanyPathwayDecision dateSource
Guidant Corp.PMA approvalJan 26, 2004FDA

Explore the linked device profile

Other records with product code NKE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Guidant Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
4100 Hamline Ave. N, St Paul, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records